Contact Person
David Munis Zepernick

Head of Communication and Public Affairs

Email: dz@mva.org
Phone: (M) +45 2498 1668
Linkedin

News

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

03 Apr

Spotlight on Sweden and Medicon Valley in “Nature”, the international journal of science

Medicon Valley Alliance has assisted the editors of Nature, the acknowledged international journal of science, with their recently published special edition “Spotlight on Sweden and Medicon Valley“. Among the articles, we specially recommend “How a bridge brought science closer together” featuring

27 Mar

Where are the most active European biotech venture capital firms located?

Which biotech venture capital firms in Europe have been most active in the past year and are likely to protagonize some of the biggest deals in European biotech in 2018? Where are they located? How do we open their eyes

16 Mar

The Medicon Valley Yearbook 2018 is out!

The Medicon Valley Yearbook 2018 has just been published. The Medicon Valley Alliance Chairman of the Board of Directors, Søren Bregenholt, Corporate Vice President, Global Research Strategy and Operations, Novo Nordisk, has used the editorial to strongly recommend that Danish

14 Mar

Danish foundation Lundbeckfonden awards The Brain Prize to four Alzheimer researchers

The four scientists are Bart De Strooper from Belgium, Michel Goedert from Luxembourg, Christian Haass from Germany and John Hardy from the UK. They are recognised for their highly specialised studies of Alzheimer’s disease and other dementia disorders and are

06 Mar

MVA-member company, Ascelia Pharma, is considering listing on the stock exchange

According to the Danish CEO of Malmø-based, Ascelia Pharma, Magnus Corfitzen, the company, which has developed a contrast agent, Mangoral, that can replace the controversial agent Omniscan, are considering several options for funding the millions of dollars need for future studies. A

02 Mar

The Greater Copenhagen Life Science Talent Attraction campaign is now up and running!

Thanks to the following six companies, Novo Nordisk, FMC, Ascendis Pharma, DTU, 3Shape and CP Kelco, our friends at Copenhagen Capacity have been able to launch their very first Life Science Talent Campaign, enabling them to attract international life science

22 Feb

Construction of European Spallation Source (ESS) campus to start in the fall

  By the end of last week, agreements were signed that will allow construction of the ESS Campus to begin this fall. The campus buildings include 18 500 square metres of offices, laboratories and workshops. The ESS Campus will consist of

10 Feb

New edition of the journal “Time to Unite A Greater Medicon Valley” published in February

The first 2018 edition of the journal “Time to Unite A Greater Medicon Valley” has just been published early February.  Apart from the editorial by MVA CEO, Petter Hartman, you can also read about Nordic Mentor Network for Entrepreneurship (NOME), the future

06 Feb

Sweden explores Danish Prehospital Care

Hosted by MVA member, Healthcare DENMARK,  a Swedish delegation consisting of representatives from The Ministry of Health and Social Affairs and The Swedish Association of Local Authorities and Regions visited Denmark on the 29th of January to see and experience innovative

Page 2 of 2712345...1020...Last »